de Zeeuw D - Search Results

1

The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.

de Zeeuw D, Navis GJ, Donker AJ, de Jong PE. de Zeeuw D, et al. Among authors: de jong pe. J Hypertens Suppl. 1983 Oct;1(1):93-7. J Hypertens Suppl. 1983. PMID: 6100614 Clinical Trial.

2

Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.

Navis GJ, de Zeeuw D, de Jong PE. Navis GJ, et al. Among authors: de jong pe, de zeeuw d. J Cardiovasc Pharmacol. 1986;8 Suppl 1:S30-4. J Cardiovasc Pharmacol. 1986. PMID: 2422491

3

Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients.

Navis G, de Jong P, Donker AJ, van der Hem GK, de Zeeuw D. Navis G, et al. Among authors: de jong p, de zeeuw d. J Cardiovasc Pharmacol. 1987 Jun;9(6):743-8. doi: 10.1097/00005344-198706000-00016. J Cardiovasc Pharmacol. 1987. PMID: 2442543 Clinical Trial.

4

Renal effects of ketanserin in essential hypertension.

Navis G, de Jong PE, van der Hem GK, de Zeeuw D. Navis G, et al. Among authors: de jong pe, de zeeuw d. J Hypertens Suppl. 1986 Apr;4(1):S95-8. J Hypertens Suppl. 1986. PMID: 2939222

5

Effects of enalaprilic acid on sodium excretion and renal hemodynamics in essential hypertension.

Navis G, de Jong PE, Donker AJ, van der Hem GK, de Zeeuw D. Navis G, et al. Among authors: de jong pe, de zeeuw d. J Clin Hypertens. 1985 Sep;1(3):228-38. J Clin Hypertens. 1985. PMID: 3012004

6

Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.

Gansevoort RT, de Zeeuw D, Shahinfar S, Redfield A, de Jong PE. Gansevoort RT, et al. Among authors: de jong pe, de zeeuw d. J Hypertens Suppl. 1994 Jul;12(2):S37-42. J Hypertens Suppl. 1994. PMID: 7965264 Clinical Trial.

7

Hypertension and renal disease: role of microalbuminuria.

Janssen WM, de Jong PE, de Zeeuw D. Janssen WM, et al. Among authors: de jong pe, de zeeuw d. J Hypertens Suppl. 1996 Dec;14(5):S173-7. J Hypertens Suppl. 1996. PMID: 9120675 Review.

8

Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.

van der Kleij FG, Schmidt A, Navis GJ, Haas M, Yilmaz N, de Jong PE, Mayer G, de Zeeuw D. van der Kleij FG, et al. Among authors: de jong pe, de zeeuw d. Kidney Int Suppl. 1997 Dec;63:S23-6. Kidney Int Suppl. 1997. PMID: 9407415 Clinical Trial.

9

Nephroptosis and kidney function.

de Zeeuw D, Donker AJ, van Herk G, Kremer E. de Zeeuw D, et al. Nephron. 1978;22(4-6):366-73. doi: 10.1159/000181477. Nephron. 1978. PMID: 740099

10

Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.

Heeg JE, de Jong PE, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Clin Sci (Lond). 1991 Sep;81(3):367-72. doi: 10.1042/cs0810367. Clin Sci (Lond). 1991. PMID: 1655338 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters